This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock ...

King Faisal Specialist Hospital & Research Centre continues to advance pediatric care through specialized programs dedicated to solid tumors and non-malignant blood disorders, supported by ...

Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...

King Faisal Specialist Hospital & Research Centre continues to strengthen its position as a leading referral center for pediatric hematology and oncology through a comprehensive care model built on ...

Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on ...

Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...

A live webcast of the presentation will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.

The Class II medical device, an AI-Automated Human Blood Cell Morphology Analyzer, received approval from the Hunan ...

Here are the top 5 articles detailing the advancements in hematologic oncology from 2025. BTK inhibitors have revolutionized ...

While multi-indication bispecific therapies are likely to expand in lymphoma, their use must remain driven by efficacy, with ...

A groundbreaking oral treatment for thalassemia, Mitapivat, has received US FDA approval, offering hope for adults with this ...

Abdullah, E.M. (2026) Intracranial Hypertension as an Initial Presentation of Polycythemia Vera: A Case Report. Open Journal ...